While large-scale GWAS have primarily established FTO’s link to obesity (Frayling et al., 2007), our results refine and extend this paradigm by demonstrating that its metabolic impact is substantially mediated through glucolipid pathways. The gene discussed is FTO; the disease is Obesity.